SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Teras Lauren R.) "

Sökning: WFRF:(Teras Lauren R.)

  • Resultat 11-14 av 14
  • Föregående 1[2]
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Vijai, Joseph, et al. (författare)
  • A genome-wide association study of marginal zone lymphoma shows association to the HLA region
  • 2015
  • Ingår i: Nature Communications. - 2041-1723 .- 2041-1723. ; 6
  • Tidskriftsartikel (refereegranskat)abstract
    • Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P - 3.95 x 10(-15)) and HLA-B (rs2922994, P - 2.43 x 10(-9)) in the HLA region significantly associated with MZL risk. This is the first evidence that genetic variation in the major histocompatibility complex influences MZL susceptibility.
12.
  • McMaster, Mary L., et al. (författare)
  • Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
  • 2018
  • Ingår i: Nature Communications. - NATURE PUBLISHING GROUP. - 2041-1723 .- 2041-1723. ; 9
  • Tidskriftsartikel (refereegranskat)abstract
    • Waldenstrom macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a rare, chronic B-cell lymphoma with high heritability. We conduct a two-stage genome-wide association study of WM/LPL in 530 unrelated cases and 4362 controls of European ancestry and identify two high-risk loci associated with WM/LPL at 6p25.3 (rs116446171, near EXOC2 and IRF4; OR = 21.14, 95% CI: 14.40-31.03, P=1.36 x 10(-)(54)) and 14q32.13 (rs117410836, near TCL1; OR = 4.90, 95% CI: 3.45-6.96, P = 8.75 x 10(-)(19)) . Both risk alleles are observed at a low frequency among controls (similar to 2-3%) and occur in excess in affected cases within families. In silico data suggest that rs116446171 may have functional importance, and in functional studies, we demonstrate increased reporter transcription and proliferation in cells transduced with the 6p25.3 risk allele. Although further studies are needed to fully elucidate underlying biological mechanisms, together these loci explain 4% of the familial risk and provide insights into genetic susceptibility to this malignancy.
13.
  • Wang, Sophia S., et al. (författare)
  • HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
  • 2018
  • Ingår i: Cancer Research. - 0008-5472 .- 1538-7445. ; 78:14, s. 4086-4096
  • Tidskriftsartikel (refereegranskat)abstract
    • A growing number of loci within the human leukocyte antigen (HLA) region have been implicated in non-Hodgkin lymphoma (NHL) etiology. Here, we test a complementary hypothesis of "heterozygote advantage" regarding the role of HLA and NHL, whereby HLA diversity is beneficial and homozygous HLA loci are associated with increased disease risk. HLA alleles at class I and II loci were imputed from genome-wide association studies (GWAS) using SNP2HLA for 3,617 diffuse large B-cell lymphomas (DLBCL), 2,686 follicular lymphomas (FL), 2,878 chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLL), 741 marginal zone lymphomas (MZL), and 8,753 controls of European descent. Both DLBCL and MZL risk were elevated with homozygosity at class I HLA-B and -C loci (OR DLBCL = 1.31, 95% CI = 1.06-1.60; OR MZL = 1.45, 95% CI = 1.12-1.89) and class II HLA-DRB1 locus (OR DLBCL = 2.10, 95% CI = 1.24-3.55; OR MZL = 2.10, 95% CI = 0.99-4.45). Increased FL risk was observed with the overall increase in number of homozygous HLA class II loci (P trend < 0.0001, FDR = 0.0005). These results support a role for HLA zygosity in NHL etiology and suggests that distinct immune pathways may underly the etiology of the different NHL subtypes. Significance: HLA gene diversity reduces risk for non-Hodgkin lymphoma.
  •  
14.
  • Gaudet, Mia M, et al. (författare)
  • Blood levels of cadmium and lead in relation to breast cancer risk in three prospective cohorts
  • 2019
  • Ingår i: International Journal of Cancer. - John Wiley & Sons. - 0020-7136. ; 144:5, s. 1010-1016
  • Tidskriftsartikel (refereegranskat)abstract
    • Cadmium and lead have been classified as carcinogens by the International Agency for Research on Cancer. However, their associations with breast cancer risk are unknown despite their persistence in the environment and ubiquitous human exposure. We examined associations of circulating levels of cadmium and lead with breast cancer risk in three case–control studies nested within the Cancer Prevention Study-II (CPS-II) LifeLink Cohort, European Prospective Investigation into Cancer and Nutrition – Italy (EPIC-Italy) and the Northern Sweden Health and Disease Study (NSHDS) cohorts. Metal levels were measured in stored erythrocytes from 1,435 cases and 1,433 controls using inductively coupled plasma-mass spectrometry. Summary relative risks (RR) and 95% confidence intervals (CI) were calculated using random-effects models with each study result weighted by the within- and between-study variances. I2 values were calculated to estimate proportion of between study variation. Using common cut-points, cadmium levels were not associated with breast cancer risk in the CPS-II cohort (continuous RR = 1.01, 95% CI 0.76–1.34), but were inversely associated with risk in the EPIC- Italy (continuous RR = 0.80, 95% CI 0.61–1.03) and NSHDS cohorts (continuous RR = 0.73, 95% CI 0.54–0.97). The inverse association was also evident in the meta-analysis (continuous RR = 0.84, 95% CI 0.69–1.01) with low between-study heterogeneity. Large differences in lead level distributions precluded a meta-analysis of their association with breast cancer risk; no associations were found in the three studies. Adult cadmium and lead levels were not associated with higher risk of breast cancer in our large meta-analysis.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-14 av 14
  • Föregående 1[2]
Åtkomst
fritt online (4)
Typ av publikation
tidskriftsartikel (14)
Typ av innehåll
refereegranskat (14)
Författare/redaktör
Berndt, Sonja I (13)
Chanock, Stephen J (13)
Kraft, Peter (13)
Bracci, Paige M (13)
Teras, Lauren R., (13)
Giles, Graham G (12)
visa fler...
Holly, Elizabeth A (12)
Lan, Qing, (12)
Rothman, Nathaniel, (12)
Melbye, Mads (11)
Diver, W. Ryan (11)
Purdue, Mark P., (11)
Glimelius, Bengt, (10)
Albanes, Demetrius (10)
Vineis, Paolo (10)
Yeager, Meredith (10)
Hjalgrim, Henrik (10)
Hutchinson, Amy (10)
Zeleniuch-Jacquotte, ... (10)
Hartge, Patricia (10)
Brennan, Paul (10)
Offit, Kenneth (10)
McKay, James (10)
Smedby, Karin E. (10)
Conde, Lucia (10)
Skibola, Christine F ... (10)
Benavente, Yolanda, (10)
Birmann, Brenda M., (10)
Cerhan, James R., (10)
Clavel, Jacqueline, (10)
Cozen, Wendy, (10)
de Sanjose, Silvia, (10)
Link, Brian K., (10)
Maynadie, Marc, (10)
Monnereau, Alain, (10)
Morton, Lindsay M., (10)
Nieters, Alexandra, (10)
Slager, Susan L., (10)
Riboli, Elio (9)
Adami, Hans Olov (9)
Boffetta, Paolo (9)
North, Kari E. (9)
Foretova, Lenka (9)
Becker, Nikolaus (9)
Spinelli, John J., (9)
Jackson, Rebecca D., (9)
Lawrence, Charles, (9)
Severson, Richard K. ... (9)
Staines, Anthony, (9)
Tinker, Lesley F., (9)
visa färre...
Lärosäte
Karolinska Institutet (11)
Uppsala universitet (10)
Umeå universitet (5)
Lunds universitet (2)
Språk
Engelska (14)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (14)
Naturvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy